Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Does tumor angiogenesis play a role in bone metastatic process?].

Olivier Peyruchaud1, Claire-Marie Serre, Roisin NicAmhlaoibh

  • 1INSERM Research Unit 403 Faculté de Médecine Laënnec Rue Guillaume Paradin F-69372 Lyon. peyruchaud@lyon.inserm.fr

Revue Medicale De La Suisse Romande
|April 21, 2004
PubMed
Summary

Angiostatin, known for inhibiting blood vessel growth, also directly reduces bone metastasis by targeting osteoclasts. This study reveals a novel dual role for angiostatin in cancer progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin Engagement and Transcriptional Activity of the ZNF217 Exon 4-Skipping Isoform Are Associated with Breast Cancer Aggressiveness and Bone Metastasis.

Cancers·2026
Same author

Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis.

Breast cancer research : BCR·2024
Same author

Voluntary exercise in mice triggers an anti-osteogenic and pro-tenogenic response in the ankle joint without affecting long bones.

Bone reports·2024
Same author

Exosome-Mediated Paracrine Signaling Unveils miR-1246 as a Driver of Aggressiveness in Fusion-Negative Rhabdomyosarcoma.

Cancers·2024
Same author

LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer.

Journal of bone oncology·2024
Same author

Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2023

Area of Science:

  • Oncology
  • Cancer Metastasis
  • Bone Biology

Context:

  • Angiogenesis is crucial for tumor growth and metastasis in many cancers.
  • The specific role of angiogenesis in bone metastasis remains largely unexplored.
  • Breast cancer bone metastasis is a significant clinical challenge.

Purpose:

  • To investigate the role of angiogenesis in bone metastasis.
  • To determine the effect of angiostatin on bone metastasis formation.
  • To elucidate the mechanism by which angiostatin influences bone metastasis.

Summary:

  • This study utilized an experimental model of bone metastasis using MDA-MB-231/B02 breast cancer cells in nude mice.
  • Results demonstrate that angiostatin inhibits bone metastasis formation.

Related Experiment Videos

  • Angiostatin exerts its inhibitory effect through both its known anti-angiogenic activity and a novel direct anti-osteoclastic activity.

    • Impact:

    • Identifies a dual mechanism of action for angiostatin in combating bone metastasis.
    • Suggests angiostatin as a potential therapeutic agent for preventing or treating bone metastases.
    • Opens new avenues for research into targeting angiogenesis and osteoclast activity in bone cancer.